Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05583110
Title Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer (TrasTUCAN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spanish Breast Cancer Research Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.